Chemoprevention of Colorectal Cancer in Inflammatory Bowel Disease / 대한소화기학회지
The Korean Journal of Gastroenterology
;
: 3-10, 2014.
Artigo
em Coreano
| WPRIM
| ID: wpr-155062
ABSTRACT
The risk of developing colorectal cancer is increased in patients with inflammatory bowel disease. Surveillance colonoscopy has not been shown to prolong survival and rates of interval cancer are reported to be high. Continuing colonic inflammation has been shown to be important in the development of colorectal cancer and therefore anti-inflammatory agents such as the 5-aminosalicylates and immunomodulators have been considered as potential chemopreventive agents. This review focuses on various chemopreventive agents that have been clearly shown to reduce the risk of colorectal adenoma and cancer in the patients with inflammatory bowel disease.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Ácido Ursodesoxicólico
/
Neoplasias Colorretais
/
Doenças Inflamatórias Intestinais
/
Quimioprevenção
/
Mesalamina
/
Ácido Fólico
/
Imunossupressores
/
Anti-Inflamatórios
Idioma:
Coreano
Revista:
The Korean Journal of Gastroenterology
Ano de publicação:
2014
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS